Carcinoembryonic antigen (CEA) is one of the most common tumor biomarkers, which has been widely used in the clinical treatment of various malignant tumors, such as colorectal cancer [5], breast cancer [6], lung cancer [7], and so on. This evidence concerns the gene CEACAM5 and breast cancer.